Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Heeney

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Vaccine|March 15, 2015
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challengeAnton M Sholukh, Jennifer D Watkins, Hemant K Vyas, et al.
Vaccines|August 6, 2021
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen SelectionJoanne Marie M Del Rosario, Kelly A S da Costa, Benedikt Asbach, et al.
Virology|April 9, 2013
Metagenomic study of the viruses of African straw-coloured fruit bats: detection of a chiropteran poxvirus and isolation of a novel adenovirusKate S Baker, Richard M Leggett, Nicholas H Bexfield, et al.
Journal of Virology|July 14, 2017
Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding SiteWilly M J M Bogers, Susan W Barnett, Herman Oostermeijer, et al.
Virology|November 28, 2006
A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivoStefan Pöhlmann, Jan Münch, Sheriff Aziz, et al.
Plos One|April 13, 2011
An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIVJennifer D Watkins, Nagadenahalli B Siddappa, Samir K Lakhashe, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2008
Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenicMax Corbett, Willy M Bogers, Jonathan L Heeney, et al.
Microbiology Spectrum|August 1, 2022
Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in NigeriaAnise N Happi, Testimony J Olumade, Olusola A Ogunsanya, et al.
Virology|October 25, 2008
Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challengeWilly M J M Bogers, David Davis, Ilona Baak, et al.
The Journal of Infectious Diseases|September 20, 2014
Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsionWilly M Bogers, Herman Oostermeijer, Petra Mooij, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Vaccine|March 15, 2015
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challengeAnton M Sholukh, Jennifer D Watkins, Hemant K Vyas, et al.
Vaccines|August 6, 2021
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen SelectionJoanne Marie M Del Rosario, Kelly A S da Costa, Benedikt Asbach, et al.
Virology|April 9, 2013
Metagenomic study of the viruses of African straw-coloured fruit bats: detection of a chiropteran poxvirus and isolation of a novel adenovirusKate S Baker, Richard M Leggett, Nicholas H Bexfield, et al.
Journal of Virology|July 14, 2017
Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding SiteWilly M J M Bogers, Susan W Barnett, Herman Oostermeijer, et al.
Virology|November 28, 2006
A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivoStefan Pöhlmann, Jan Münch, Sheriff Aziz, et al.
Plos One|April 13, 2011
An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIVJennifer D Watkins, Nagadenahalli B Siddappa, Samir K Lakhashe, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2008
Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenicMax Corbett, Willy M Bogers, Jonathan L Heeney, et al.
Microbiology Spectrum|August 1, 2022
Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in NigeriaAnise N Happi, Testimony J Olumade, Olusola A Ogunsanya, et al.
Virology|October 25, 2008
Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challengeWilly M J M Bogers, David Davis, Ilona Baak, et al.
The Journal of Infectious Diseases|September 20, 2014
Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsionWilly M Bogers, Herman Oostermeijer, Petra Mooij, et al.
Pageof 12